In the BioHarmony Drug Report Database
Pimecrolimus
Elidel (pimecrolimus) is a small molecule pharmaceutical. Pimecrolimus was first approved as Elidel on 2001-12-13. It is used to treat atopic dermatitis in the USA. The pharmaceutical is active against peptidyl-prolyl cis-trans isomerase FKBP1A.
Trade Name
|
Elidel |
|---|---|
Common Name
|
pimecrolimus |
ChEMBL ID
|
CHEMBL1200686 |
Indication
|
atopic dermatitis |
Drug Class
|
Immunosuppressives: immunosuppressant, rapamycin derivatives |
Image (chem structure or protein)